Constellation Brands enters its rescheduled July 22 earnings window with the Street freshly split and the stock still trading well below where most analysts think it belongs.
The analyst picture is the standout story this week. The direction of travel is broadly constructive but shot through with uncertainty. Wells Fargo trimmed its target to $170 from $185 on June 29, keeping an Overweight — a meaningful cut that signals reduced near-term confidence even from a bull. TD Cowen's fresh Buy initiation at $174 and Needham's reiteration at $185 on June 26 pull the other way, as does JP Morgan's marginal target nudge to $169. BofA remains the most structurally sceptical voice, holding an Underperform at $152. With the stock at $139.09, the consensus cluster of targets between $157 and $185 implies the Street broadly sees 13–33% upside — a wide range that reflects genuine disagreement on the pace of beer category recovery rather than a unified view. Piper Sandler reiterated Neutral at $160 on July 1, adding one more name to the cautious middle ground.
The bull case rests on Modelo and Corona's durable share within the Hispanic consumer segment, the exclusive Mexican import licence as a hard-to-replicate competitive moat, and the expectation that soft depletion trends reverse as macro pressure eases. Bears counter that the company's FY27 guidance already disappointed, import concentration leaves earnings exposed to tariff risk and peso moves, and the Canopy Growth overhang has yet to fully clear. Factor scores tilt toward the sceptics on momentum and earnings trajectory: EPS momentum ranks in the bottom quarter of the universe over both 30-day and 90-day windows, and the 12-month forward EPS growth score sits at just 15. The dividend score at 85 is the one bright spot in the factor picture — though the dividend data in the snapshot is stale, so treat that ranking as a structural rather than current read.
Positioning has calmed materially since the pre-June 26 spike that dominated coverage for most of the month. Short interest is now 4.37% of the free float — down roughly 4% on the week and off the mid-June high near 4.7%, confirming the short-trimming trend noted in prior pieces. Borrow availability remains extraordinarily loose at over 2,000%, meaning shares available to lend dwarf the shares already borrowed. There is no squeeze dynamic building here. Cost to borrow has crept up 38% over the past week to 0.44%, which looks alarming in percentage terms but remains negligibly low in absolute terms — this is emphatically not a stock where the lending market is sending distress signals. Options have similarly settled. The put/call ratio at 0.87 is modestly above its 20-day average of 0.84 but less than one standard deviation elevated — a sharp normalisation from the two-to-three standard deviation defensive extremes seen ahead of June 26.
The one ownership detail worth flagging is Berkshire Hathaway's position, which shrank by 12.4 million shares in the most recent reported quarter to just under 633,000. That is a dramatic reduction from a previously meaningful stake, and it removes a high-profile endorsement that had historically supported the bull narrative. BlackRock added 244,000 shares and now holds 6.5% — the largest institutional block — but passive accumulation reads differently than active conviction.
The peer tape offers mild context. TAP fell around 2% on the week, broadly in line with STZ's 3% decline. BF.B dropped similarly. PEP was the week's notable underperformer among close correlates, down nearly 5%, suggesting the broader consumer staples complex is under the same macro weight rather than anything STZ-specific. The next clear event is the July 22 earnings print — where the width of the analyst target range means the market's reaction will depend heavily on whether depletion trends give the bulls or the bears the better argument.
See the live data behind this article on ORTEX.
Open STZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
